ClinicalTrials.gov
public full text
Public Domain
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
The purpose of this study is to determine the safety and feasibility of using intra-arterial Tenecteplase in patients undergoing blood clot extraction for treatment of acute ischemic (non-bleeding) stroke. Intravenous Tenecteplase is FDA-approved to treat patients with an ischemic stroke presenting within the 0-3-hour time window.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparative effectiveness of Tenecteplase and Alteplase for ischemic stroke : real-world data from a stroke center#1390957
- Thrombolysis With Tenecteplase for Minor Disabling Stroke#263422
- CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II#1093974
- Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)#1375441
- Tenecteplase in Stroke Patients Between 4.5 and 24 Hours#890154
Record · ID 1411077
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive